Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 45.341
Filtrer
1.
Front Cell Infect Microbiol ; 14: 1414188, 2024.
Article de Anglais | MEDLINE | ID: mdl-38979511

RÉSUMÉ

In Escherichia coli, the disaccharide trehalose can be metabolized as a carbon source or be accumulated as an osmoprotectant under osmotic stress. In hypertonic environments, E. coli accumulates trehalose in the cell by synthesis from glucose mediated by the cytosolic enzymes OtsA and OtsB. Trehalose in the periplasm can be hydrolyzed into glucose by the periplasmic trehalase TreA. We have previously shown that a treA mutant of extraintestinal E. coli strain BEN2908 displayed increased resistance to osmotic stress by 0.6 M urea, and reduced production of type 1 fimbriae, reduced invasion of avian fibroblasts, and decreased bladder colonization in a murine model of urinary tract infection. Since loss of TreA likely results in higher periplasmic trehalose concentrations, we wondered if deletion of otsA and otsB genes, which would lead to decreased internal trehalose concentrations, would reduce resistance to stress by 0.6 M urea and promote type 1 fimbriae production. The BEN2908ΔotsBA mutant was sensitive to osmotic stress by urea, but displayed an even more pronounced reduction in production of type 1 fimbriae, with the consequent reduction in adhesion/invasion of avian fibroblasts and reduced bladder colonization in the murine urinary tract. The BEN2908ΔtreAotsBA mutant also showed a reduction in production of type 1 fimbriae, but in contrast to the ΔotsBA mutant, resisted better than the wild type in the presence of urea. We hypothesize that, in BEN2908, resistance to stress by urea would depend on the levels of periplasmic trehalose, but type 1 fimbriae production would be influenced by the levels of cytosolic trehalose.


Sujet(s)
Fimbriae bactériens , Osmorégulation , Tréhalose , Vessie urinaire , Infections urinaires , Animaux , Tréhalose/métabolisme , Souris , Vessie urinaire/microbiologie , Fimbriae bactériens/métabolisme , Fimbriae bactériens/génétique , Infections urinaires/microbiologie , Infections à Escherichia coli/microbiologie , Protéines Escherichia coli/métabolisme , Protéines Escherichia coli/génétique , Escherichia coli/métabolisme , Escherichia coli/génétique , Modèles animaux de maladie humaine , Femelle , Pression osmotique , Escherichia coli pathogènes extra-intestinales/métabolisme , Escherichia coli pathogènes extra-intestinales/génétique , Urée/métabolisme , alpha, alpha-Trehalase/métabolisme , alpha, alpha-Trehalase/génétique , Délétion de gène , Glucose/métabolisme
2.
Investig Clin Urol ; 65(4): 378-390, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38978218

RÉSUMÉ

PURPOSE: To investigate urine microbiome differences among healthy women, women with recurrent uncomplicated cystitis (rUC), and those with sporadic/single uncomplicated cystitis (sUC) to challenge traditional beliefs about origins of these infections. MATERIALS AND METHODS: Patients who underwent both conventional urine culture and next-generation sequencing (NGS) of urine were retrospectively reviewed. Symptom-free women with normal urinalysis results as a control group were also studied. Samples were collected via transurethral catheterization. RESULTS: In the control group, urine microbiome was detected on NGS in 83.3%, with Lactobacillus and Prevotella being the most abundant genera. The sensitivity of urine NGS was significantly higher than that of conventional urine culture in both the sUC group (91.2% vs. 32.4%) and the rUC group (82.4% vs. 16.4%). In urine NGS results, Enterobacterales, Prevotella, and Escherichia/Shigella were additionally found in the sUC group, while the recurrent urinary tract infection (rUTI)/rUC group exhibited the presence of Lactobacillus, Prevotella, Enterobacterales, Escherichia/Shigella, and Propionibacterium. Moreover, distinct patterns of urine NGS were observed based on menopausal status and ingestion of antibiotics or probiotics prior to NGS test sampling. CONCLUSIONS: Urine microbiomes in control, sUC, and rUTI/rUC groups exhibited distinct characteristics. Notably, sUC and rUC might represent entirely separate pathological processes, given their distinct urine microbiomes. Consequently, the use of urine NGS might be essential to enhancing sensitivity compared to conventional urine culture in both sUC and rUTI/rUC groups.


Sujet(s)
Cystite , Microbiote , Récidive , Humains , Femelle , Cystite/microbiologie , Cystite/urine , Études rétrospectives , Adulte d'âge moyen , Adulte , Urine/microbiologie , République de Corée , Séquençage nucléotidique à haut débit , Maladie aigüe , Infections urinaires/microbiologie , Sujet âgé , Pertinence clinique
3.
BMC Med Genomics ; 17(1): 183, 2024 Jul 09.
Article de Anglais | MEDLINE | ID: mdl-38982318

RÉSUMÉ

BACKGROUND AND PURPOSE: The association of water loading with several infections remains unclear. Observational studies are hard to investigate definitively due to potential confounders. In this study, we employed Mendelian randomization (MR) analysis to assess the association between genetically predicted whole body water mass (BWM) and several infections. METHODS: BWM levels were predicted among 331,315 Europeans in UK Biobank using 418 SNPs associated with BWM. For outcomes, we used genome-wide association data from the UK Biobank and FinnGen consortium, including sepsis, pneumonia, intestinal infections, urinary tract infections (UTIs) and skin and soft tissue infections (SSTIs). Inverse-variance weighted MR analyses as well as a series of sensitivity analyses were conducted. RESULTS: Genetic prediction of BWM is associated with an increased risk of sepsis (OR 1.34; 95% CI 1.19 to 1.51; P = 1.57 × 10- 6), pneumonia (OR: 1.17; 95% CI 1.08 to 1.29; P = 3.53 × 10- 4), UTIs (OR: 1.26; 95% CI 1.16 to 1.37; P = 6.29 × 10- 8), and SSTIs (OR: 1.57; 95% CI 1.25 to 1.96; P = 7.35 × 10- 5). In the sepsis and pneumonia subgroup analyses, the relationship between BWM and infection was observed in bacterial but not in viral infections. Suggestive evidence suggests that BWM has an effect on viral intestinal infections (OR: 0.86; 95% CI 0.75 to 0.99; P = 0.03). There is limited evidence of an association between BWM levels and bacteria intestinal infections, and genitourinary tract infection (GUI) in pregnancy. In addition, MR analyses supported the risk of BWM for several edematous diseases. However, multivariable MR analysis shows that the associations of BWM with sepsis, pneumonia, UTIs and SSTIs remains unaffected when accounting for these traits. CONCLUSIONS: In this study, the causal relationship between BWM and infectious diseases was systematically investigated. Further prospective studies are necessary to validate these findings.


Sujet(s)
Infections bactériennes , Étude d'association pangénomique , Analyse de randomisation mendélienne , Polymorphisme de nucléotide simple , Humains , Infections bactériennes/génétique , Femelle , Facteurs de risque , Mâle , Infections urinaires/génétique , Infections urinaires/microbiologie , Sepsie/génétique , Sepsie/microbiologie
4.
Curr Microbiol ; 81(9): 276, 2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39023551

RÉSUMÉ

Klebsiella pneumoniae is an opportunistic pathogen mostly found in health care-associated infections but can also be associated with community-acquired infections and is in critical need of new antimicrobial agents for strains resistant to carbapenems. The prevalence of carbapenemase-encoding genes varies among studies. Multidrug-resistant K. pneumoniae strains can harbor several antimicrobial-resistant determinants and mobile genetic elements (MGEs), along with virulence genetic determinants in community settings. We aim to determine the genetic profile of a multidrug-resistant K. pneumoniae strain isolated from a patient with community-acquired UTI. We isolated a K. pneumoniae strain UABC-Str0120, from a urine sample of community-acquired urinary tract infection. Antimicrobial susceptibility tests and Whole-genome sequencing (WGS) were performed. The phylogenetic relationship was inferred by SNPs calling and filtering. UABC-Str0120 showed resistance toward ß-lactams, combinations with ß-lactamase inhibitors, and carbapenems. WGS revealed the presence of genes conferring resistance to aminoglycosides, ß-lactams, carbapenems, quinolones, sulfonamides, phosphonates, phenicols, and quaternary ammonium compounds, 77 subsystems of virulence genes were identified, and an uncommon sequence type ST5889 was also determined. The sequenced strain harbors several MGEs. The UABC-Str0120 recovered from a urine sample harbors several virulence and antimicrobial resistance determinants, which assembles an endangering combination for an immunocompromised or a seemly healthy host, given its presence in a community setting.


Sujet(s)
Antibactériens , Multirésistance bactérienne aux médicaments , Génome bactérien , Infections à Klebsiella , Klebsiella pneumoniae , Tests de sensibilité microbienne , Phylogenèse , Infections urinaires , Séquençage du génome entier , Klebsiella pneumoniae/génétique , Klebsiella pneumoniae/effets des médicaments et des substances chimiques , Klebsiella pneumoniae/isolement et purification , Humains , Multirésistance bactérienne aux médicaments/génétique , Infections à Klebsiella/microbiologie , Infections à Klebsiella/urine , Antibactériens/pharmacologie , Infections urinaires/microbiologie , Infections communautaires/microbiologie , Urine/microbiologie
5.
Birth Defects Res ; 116(7): e2377, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38946111

RÉSUMÉ

BACKGROUND: Gastroschisis is a congenital anomaly of the umbilical ring with increasing prevalence, especially amongst younger mothers. There is increasing evidence that exposure to genitourinary infections (GUTI) may play an important role in the etiology of gastroschisis. This systematic review and meta-analysis aimed to identify, appraise, and summarize the literature on exposure to GUTI and gastroschisis. METHODS: Six electronic databases (MEDLINE, EMBASE, Web of Science, Scopus, Cochrane Library electronic databases, and Prospero) were searched using a comprehensive search strategy. Citations and cited articles for all included studies were searched. Peer-reviewed, quantitative studies reporting an association of urinary tract infections (UTI) and/or sexually transmitted infections (STI) with gastroschisis were included. Prospero registration CRD42022377420. RESULTS: A total of 2392 papers were identified via the searches of which 15 met our inclusion criteria and were included after title and abstract and full text screening. The study period for included studies ranged from 1995 to 2016, most were from the USA. Four studies considering exposure to STIs and five to UTIs were eligible to progress to meta-analysis. Meta-analysis identified a significantly increased risk of gastroschisis in association with periconceptional exposure to UTI [OR 1.54 (95% CI 1.29, 1.8)], STI [OR 1.4 (95% CI 1.01, 1.79)]. CONCLUSIONS: Periconceptional exposure to GUTI is associated with an increased risk of gastroschisis. The prevention and timely treatment of GUTI amongst women of childbearing age may help to reduce the occurrence of gastroschisis.


Sujet(s)
Laparoschisis , Infections urinaires , Femelle , Humains , Grossesse , Laparoschisis/épidémiologie , Prévalence , Facteurs de risque , Maladies sexuellement transmissibles/complications , Maladies sexuellement transmissibles/épidémiologie , Infections urinaires/complications , Infections urinaires/épidémiologie
7.
J Pak Med Assoc ; 74(6): 1094-1098, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38948978

RÉSUMÉ

OBJECTIVE: To analyse the preva lence of complications related to out-of-hospital cardiac arrest patients achieving target temperature management within 360 minutes compared to those taking more than 360 minutes. METHODS: The retrospective study was conducted at a medical centre in Taiwan, and comprised data from Januar y 1, 2014, to December 31, 2020. Data was retrieved using the International Classification of Diseases version 10 codes I46.2, I46.8 and I46.9 related to adult patients of either gender presenting to the Emergenc y Medicine department with out-of-hospital cardiac arrest. Data included gender, age, medical histor y, body mass index, acute physiology and chronic health evaluation II score, blood glucose levels, electrocardiogram results, and complications occurring within the target temperature management timeframe. Data was divided into group A having patients who achieved target temperature management within 360 minutes, and group B having patients with delayed TTM of more than 360 minutes. Data was analysed using SPSS 22. RESULTS: Of the 127 patients, 76(59%) were males, 51(41%) were females,, 47(37%) were aged >75 years, and 13(10.3%) were aged <50 years. Of the total, 65(51.2%) patients were in group A, and 62(48.8%) were in group B. Pneumonia, urinary tract infection, septic shock and gastrointestinal bleeding had lower incidence rates in group A than group B (p<0.05). The odds of death were 2.879 times high er in group B patients than group A (95% confidence interval: 1.908-8.916). CONCLUSIONS: Hypothermia tre atment should be sta rted as soon as pos sible to achieve target temp erature management within 360 minutes to reduce the risk of complications and mortality.


Sujet(s)
Arrêt cardiaque hors hôpital , Humains , Mâle , Femelle , Adulte d'âge moyen , Études rétrospectives , Sujet âgé , Arrêt cardiaque hors hôpital/thérapie , Taïwan/épidémiologie , Hypothermie provoquée/méthodes , Adulte , Facteurs temps , Hémorragie gastro-intestinale/épidémiologie , Infections urinaires/épidémiologie , Pneumopathie infectieuse/épidémiologie , Choc septique/thérapie , Choc septique/épidémiologie
8.
BMC Prim Care ; 25(1): 234, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38951826

RÉSUMÉ

BACKGROUND: Urinary tract infections (UTI) affect almost two-thirds of all women during their lives and many experience recurrent infections. There are evidence-based guidelines from multiple international societies for evaluation and treatment; however, recent claims-based analyses have demonstrated that adherence to these guidelines is poor. This study seeks to understand the barriers experienced by U.S. primary care providers (PCPs) to providing guideline-based care for UTI and recurrent UTI (rUTI). METHODS: Semi-structured interviews of 18 PCPs, recruited from the greater Los Angeles area, examined real-world clinical management of UTI/rUTI episodes, decisions to refer to subspecialty care, and resources guiding counseling and management. Grounded theory methodology served to analyze interview transcripts and identify preliminary and major themes. RESULTS: Participants expressed the desire to obtain urine cultures for each cystitis episode, but felt pressured to make compromises by patient demands or barriers to care. PCPs had lower thresholds to empirical treatment if patients had a history of rUTIs, were elderly, or declined evaluation. Laboratory data was minimally utilized in clinical decision-making: urinalyses were infrequently considered when interpreting culture data. PCPs treated a broad set of urologic and non-urologic symptoms as UTI, even with negative cultures. PCPs did not feel comfortable initiating UTI prophylaxis, instead seeking specialist evaluation for anatomic causes. They were unaware of management guidelines, typically utilizing UpToDate® as their primary resource. Few evidence-based UTI prevention interventions were recommended by providers. CONCLUSIONS: Low availability of succinct and clear professional guidelines are substantial barriers to appropriate UTI/rUTI care. Poor useability of clinical guidance documents results in substantial confusion about the role of preventative measures and additional diagnostic testing. Difficulties in patient access to care providers lead to expectations for presumptive treatment. Future studies are needed to determine if improved educational materials for providers and/or management algorithms can improve guideline concordance of UTI management.


Sujet(s)
Attitude du personnel soignant , Adhésion aux directives , Médecins de premier recours , Guides de bonnes pratiques cliniques comme sujet , Recherche qualitative , Infections urinaires , Humains , Infections urinaires/thérapie , Médecins de premier recours/psychologie , Femelle , Mâle , Récidive , Adulte d'âge moyen , Adulte , États-Unis , Types de pratiques des médecins , Entretiens comme sujet , Orientation vers un spécialiste
9.
Tech Coloproctol ; 28(1): 77, 2024 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-38954131

RÉSUMÉ

BACKGROUND: Bladder drainage is systematically used in rectal cancer surgery; however, the optimal type of drainage, transurethral catheterization (TUC) or suprapubic catheterization (SPC), is still controversial. The aim was to compare the rates of urinary tract infection on the fourth postoperative day (POD4) between TUC and SPC, after rectal cancer surgery regardless of the day of removal of the urinary drain. METHODS: This randomized clinical trial in 19 expert colorectal surgery centers in France and Belgium was performed between October 2016 and October 2019 and included 240 men (with normal or subnormal voiding function) undergoing mesorectal excision with low anastomosis for rectal cancer. Patients were followed at postoperative days 4, 30, and 180. RESULTS: In 208 patients (median age 66 years [IQR 58-71]) randomized to TUC (n = 99) or SPC (n = 109), the rate of urinary infection at POD4 was not significantly different whatever the type of drainage (11/99 (11.1%) vs. 8/109 (7.3%), 95% CI, - 4.2% to 11.7%; p = 0.35). There was significantly more pyuria in the TUC group (79/99 (79.0%) vs. (60/109 (60.9%), 95% CI, 5.7-30.0%; p = 0.004). No difference in bacteriuria was observed between the groups. Patients in the TUC group had a shorter duration of catheterization (median 4 [2-5] vs. 4 [3-5] days; p = 0.002). Drainage complications were more frequent in the SPC group at all followup visits. CONCLUSIONS: TUC should be preferred over SPC in male patients undergoing surgery for mid and/or lower rectal cancers, owing to the lower rate of complications and shorter duration of catheterization. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02922647.


Sujet(s)
Drainage , Complications postopératoires , Tumeurs du rectum , Cathétérisme urinaire , Infections urinaires , Humains , Mâle , Tumeurs du rectum/chirurgie , Adulte d'âge moyen , Sujet âgé , Cathétérisme urinaire/méthodes , Cathétérisme urinaire/effets indésirables , Drainage/méthodes , Infections urinaires/étiologie , Infections urinaires/prévention et contrôle , Infections urinaires/épidémiologie , Complications postopératoires/étiologie , Complications postopératoires/épidémiologie , Vessie urinaire/chirurgie , Belgique
11.
J Med Case Rep ; 18(1): 326, 2024 Jul 17.
Article de Anglais | MEDLINE | ID: mdl-39014508

RÉSUMÉ

BACKGROUND: Escherichia coli is a major human pathogen responsible for a broad range of clinical illnesses. It has been linked to endemic and epidemic nosocomial diseases caused by multidrug-resistant pathogens in Sudan as well as throughout the globe. CASE PRESENTATION: A 76-year-old African woman arrived at Saad Rashwan Medical Centre complaining of backaches and discomfort during urination. Throughout the preceding 5 years, the patient had recurrent urinary tract infections. Following overnight incubation at 37 °C, Escherichia coli was found in her midstream urine specimen on cysteine lactose electrolyte deficient agar media. Minimum inhibitory concentration (colorimetric/turbidimetric method) was employed to test a wide range of antimicrobial drugs against this bacterial strain, and the results revealed significant multidrug resistance. QIAamp® DNA Mini Kit was used to obtain DNA Template from the purified Escherichia coli (Qiagen, Hilden, Germany). The bacterial whole-genome sequence was done by Novogene company (Hong Kong) using Illumina HiSeq 2500 (Illumina, San Diego, CA, USA), followed by whole genome reconstructions, and identification of antibiotic-resistant genes. Phylogenetic analysis revealed that our strain was related to the Escherichia coli DSM30083 ( genome sequence ID: CP033092.2) from the USA. Our strain possessed the following antimicrobial-resistant genes: aminoglycoside (kdpE, baeR, cpxA, aadA5), nitroimidazole (msbA), phosphonic acid (mdtG), tetracycline (emrY), macrolide, penam, tetracycline, (evgA, TolC, H-NS), fluoroquinolone, cephalosporin, glycylcycline, penam, tetracycline, rifamycin, phenicol antibiotic, disinfecting agents and antiseptics (acrB; marA), sulfonamide (sul1), macrolide (Mrx), cephalosporin, penam (CTX-M-15), carbapenem, cephalosporin, and penam (OXA-1). CONCLUSION: This study found that the isolated Escherichia coli strain had varied antimicrobial resistance genes on the basis of whole-genome sequencing and phenotypic resistance analyses. Whole-genome sequencing is critical for control and preventative methods to battle the growing threat of antimicrobial resistance. A larger investigation is recommended for improved generalization of results.


Sujet(s)
Multirésistance bactérienne aux médicaments , Infections à Escherichia coli , Escherichia coli , Sujet immunodéprimé , Infections urinaires , Séquençage du génome entier , Humains , Infections urinaires/microbiologie , Infections urinaires/traitement médicamenteux , Femelle , Sujet âgé , Multirésistance bactérienne aux médicaments/génétique , Infections à Escherichia coli/traitement médicamenteux , Infections à Escherichia coli/microbiologie , Escherichia coli/génétique , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/isolement et purification , Antibactériens/usage thérapeutique , Antibactériens/pharmacologie , Tests de sensibilité microbienne , Phylogenèse
12.
Hinyokika Kiyo ; 70(5): 111-115, 2024 May.
Article de Japonais | MEDLINE | ID: mdl-38966920

RÉSUMÉ

Intermittent balloon catheterization with a reusable and temporary balloon catheter that could be implanted and removed by the patient was developed in Japan in 1995. Although the intermittent balloon catheter has the potential to improve the patient's quality of life (QOL), appropriate information and guidelines are needed to prevent complications such as hematuria and urinary tract infection. This study aimed to assess the real-world practice, complications, and problems associated with the use of intermittent balloon catheters and provide useful information for future medical care. We conducted a questionnaire survey on patients with spinal cord lesions who currently use or have used intermittent balloon catheters in the past. Seventy-six patients with spinal cord lesions who visited Kanagawa Rehabilitation Hospital from August 2020 to March 2021 and gave consent for participating in this study were included. QOL scores before and after intermittent balloon catheter use showed significant improvement after use. Forty-six of the 76 (61.3%) patients had complications. Overall complications were significantly associated with male sex and possibly linked to non-traumatic spinal cord lesions.


Sujet(s)
Qualité de vie , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Enquêtes et questionnaires , Adulte , Sujet âgé de 80 ans ou plus , Infections urinaires/étiologie , Infections urinaires/prévention et contrôle , Traumatismes de la moelle épinière , Hématurie/étiologie
13.
Arch Esp Urol ; 77(5): 525-530, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38982781

RÉSUMÉ

OBJECTIVE: Urinary tract infections (UTIs) are the most common bacterial infection during pregnancy. This study aimed to investigate the risk factors of UTI during pregnancy. METHODS: In this study, pregnant women who underwent prenatal examination in our hospital from October 2019 to October 2023 were divided into UTI group and non-UTI group in accordance with whether or not they had a UTI. The general data, clinical data and laboratory indicators of the participants were collected. Multivariate logistic regression was used to analyse the influencing factors of UTI in pregnant women, and the results were shown with odds ratio (OR) and 95% confidence interval (95% CI). RESULTS: A total of 600 pregnant women were included in the study. The results found that 56 women (9.33%) had a combined UTI. The results of midstream urinary bacterial culture in the UTI group showed that Gram-negative bacteria accounted for 60.71% of all detected pathogenic bacteria, and Escherichia coli and Staphylococcus aureus were common strains, accounting for 46.43% and 23.21%, respectively. The proportions of patients in the UTI group who were ≥35 years old, had a high school education or below, had a history of abortion, had gestational diabetes, had ≥three vaginal and anal examinations, had a history of UTI and had urinary tract stones were significantly higher than the non-UTI group (p < 0.05). Multivariate logistic regression analysis showed that age ≥35 years (OR = 9.127; 95% CI: 4.668-17.810; p < 0.001), educational level of high school or lower (OR = 4.184; 95% CI: 2.448-7.160; p < 0.001), gestational diabetes (OR = 3.494; 95% CI: 1.789-6.803; p < 0.001), UTI history (OR = 2.074; 95% CI: 1.114-3.834; p < 0.001) and haemoglobin (Hb) <100 g/L (OR = 8.022; 95% CI: 4.532-14.325; p < 0.001) are risk factors for UTI in pregnant women. CONCLUSIONS: The common pathogenic bacteria of pregnant women with UTI are mainly Gram-negative bacteria. Older pregnant women, low educational level, gestational diabetes mellitus, history of UTI and anaemia may be risk factors for UTI in pregnant women.


Sujet(s)
Complications infectieuses de la grossesse , Infections urinaires , Humains , Femelle , Infections urinaires/épidémiologie , Grossesse , Études rétrospectives , Facteurs de risque , Adulte , Complications infectieuses de la grossesse/épidémiologie , Appréciation des risques , Jeune adulte
14.
Arch Esp Urol ; 77(5): 577-583, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38982787

RÉSUMÉ

OBJECTIVES: Indwelling urinary catheter is closely associated with the occurrence of urinary tract infection (UTI). Herein, we further explored the correlation of urinary catheter indwelling time and UTI. METHODS: Retrospectively, the medical data of nosocomial patients (n = 681) were collected during two quarters of April 2023 to June 2023 (the second quarter, 23.4-23.6, n = 330) and July 2023 to September 2023 (the third quarter, 23.7-23.9, n = 351). The baseline data and incidence of catheter-related UTI were analysed. The total hospitalisation days and indwelling urinary catheter days of patients in five departments were assessed, namely, coronary care unit (CCU), respiratory intensive care unit (RICU), surgical intensive care unit (SICU), neurology intensive care unit (NICU) and cardiac surgical intensive care unit (CSICU) departments. The correlation between hospitalisation days/indwelling urinary catheter days and the occurrence of UTI was evaluated by Spearman correlation analysis. RESULTS: In the CCU, RICU, SICU, NICU and CSICU departments, the number of patients was 463, 83, 29, 91 and 15, respectively. During 23.4-23.6, the incidence of catheter-associated UTI (CAUTI) was 0, 2.85, 6.12, 0 and 12.99 per 1000 urinary catheter days in CCU, RICU, SICU, NICU and CSICU, respectively. During 23.7-23.9, the incidence of CAUTI was 2.98, 6.13, 8.66, 0 and 0 per 1000 urinary catheter days in CCU, RICU, SICU, NICU and CSICU, respectively. Notably, hospitalisation days/indwelling urinary catheter days were positively correlated with the occurrence of CAUTI in each quarter (p < 0.05). CONCLUSIONS: There was a positive correlation between urinary catheter indwelling time and the occurrence of UTI.


Sujet(s)
Infections sur cathéters , Cathéters à demeure , Infection croisée , Cathéters urinaires , Infections urinaires , Humains , Infections urinaires/épidémiologie , Infections urinaires/étiologie , Études rétrospectives , Mâle , Femelle , Adulte d'âge moyen , Cathéters à demeure/effets indésirables , Infection croisée/épidémiologie , Infection croisée/étiologie , Facteurs temps , Cathéters urinaires/effets indésirables , Infections sur cathéters/épidémiologie , Infections sur cathéters/étiologie , Sujet âgé , Cathétérisme urinaire/effets indésirables , Incidence , Corrélation de données
15.
Arch Microbiol ; 206(8): 344, 2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-38967798

RÉSUMÉ

Uropathogenic Escherichia coli, the most common cause for urinary tract infections, forms biofilm enhancing its antibiotic resistance. To assess the effects of compounds on biofilm formation of uropathogenic Escherichia coli UMN026 strain, a high-throughput combination assay using resazurin followed by crystal violet staining was optimized for 384-well microplate. Optimized assay parameters included, for example, resazurin and crystal violet concentrations, and incubation time for readouts. For the assay validation, quality parameters Z' factor, coefficient of variation, signal-to-noise, and signal-to-background were calculated. Microplate uniformity, signal variability, edge well effects, and fold shift were also assessed. Finally, a screening with known antibacterial compounds was conducted to evaluate the assay performance. The best conditions found were achieved by using 12 µg/mL resazurin for 150 min and 0.023% crystal violet. This assay was able to detect compounds displaying antibiofilm activity against UMN026 strain at sub-inhibitory concentrations, in terms of metabolic activity and/or biomass.


Sujet(s)
Antibactériens , Biofilms , Chlorure de méthylrosanilinium , Tests de criblage à haut débit , Oxazines , Escherichia coli uropathogène , Xanthènes , Biofilms/effets des médicaments et des substances chimiques , Biofilms/croissance et développement , Escherichia coli uropathogène/effets des médicaments et des substances chimiques , Escherichia coli uropathogène/physiologie , Tests de criblage à haut débit/méthodes , Xanthènes/composition chimique , Antibactériens/pharmacologie , Chlorure de méthylrosanilinium/métabolisme , Oxazines/pharmacologie , Oxazines/métabolisme , Oxazines/composition chimique , Tests de sensibilité microbienne , Infections urinaires/microbiologie , Humains
16.
BMC Infect Dis ; 24(1): 674, 2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-38969966

RÉSUMÉ

BACKGROUND: Device-associated infections (DAIs) are a significant cause of morbidity following living donor liver transplantation (LDLT). We aimed to assess the impact of bundled care on reducing rates of device-associated infections. METHODS: We performed a before-and-after comparative study at a liver transplantation facility over a three-year period, spanning from January 2016 to December 2018. The study included a total of 57 patients who underwent LDLT. We investigated the implementation of a care bundle, which consists of multiple evidence-based procedures that are consistently performed as a unified unit. We divided our study into three phases and implemented a bundled care approach in the second phase. Rates of pneumonia related to ventilators [VAP], bloodstream infections associated with central line [CLABSI], and urinary tract infections associated with catheters [CAUTI] were assessed throughout the study period. Bacterial identification and antibiotic susceptibility testing were performed using the automated Vitek-2 system. The comparison between different phases was assessed using the chi-square test or the Fisher exact test for qualitative values and the Kruskal-Wallis H test for quantitative values with non-normal distribution. RESULTS: In the baseline phase, the VAP rates were 73.5, the CAUTI rates were 47.2, and the CLABSI rates were 7.4 per one thousand device days (PDD). During the bundle care phase, the rates decreased to 33.3, 18.18, and 4.78. In the follow-up phase, the rates further decreased to 35.7%, 16.8%, and 2.7% PDD. The prevalence of Klebsiella pneumonia (37.5%) and Methicillin resistance Staph aureus (37.5%) in VAP were noted. The primary causative agent of CAUTI was Candida albicans, accounting for 33.3% of cases, whereas Coagulase-negative Staph was the predominant organism responsible for CLABSI, with a prevalence of 40%. CONCLUSION: This study demonstrates the effectiveness of utilizing the care bundle approach to reduce DAI in LDLT, especially in low socioeconomic countries with limited resources. By implementing a comprehensive set of evidence-based interventions, healthcare systems can effectively reduce the burden of DAI, enhance infection prevention strategies and improve patient outcomes in resource-constrained settings.


Sujet(s)
Infections sur cathéters , Transplantation hépatique , Donneur vivant , Bouquets de soins des patients , Centres de soins tertiaires , Humains , Transplantation hépatique/effets indésirables , Centres de soins tertiaires/statistiques et données numériques , Femelle , Mâle , Égypte/épidémiologie , Infections sur cathéters/épidémiologie , Infections sur cathéters/prévention et contrôle , Infections sur cathéters/microbiologie , Adulte , Adulte d'âge moyen , Bouquets de soins des patients/méthodes , Pneumopathie infectieuse sous ventilation assistée/prévention et contrôle , Pneumopathie infectieuse sous ventilation assistée/épidémiologie , Pneumopathie infectieuse sous ventilation assistée/microbiologie , Infections urinaires/épidémiologie , Infections urinaires/prévention et contrôle , Infections urinaires/microbiologie
17.
Proc Natl Acad Sci U S A ; 121(29): e2400666121, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-38976738

RÉSUMÉ

Urinary tract infection (UTI) commonly afflicts people with diabetes. This augmented infection risk is partly due to deregulated insulin receptor (IR) signaling in the kidney collecting duct. The collecting duct is composed of intercalated cells (ICs) and principal cells (PCs). Evidence suggests that ICs contribute to UTI defenses. Here, we interrogate how IR deletion in ICs impacts antibacterial defenses against uropathogenic Escherichia coli. We also explore how IR deletion affects immune responses in neighboring PCs with intact IR expression. To accomplish this objective, we profile the transcriptomes of IC and PC populations enriched from kidneys of wild-type and IC-specific IR knock-out mice that have increased UTI susceptibility. Transcriptomic analysis demonstrates that IR deletion suppresses IC-integrated stress responses and innate immune defenses. To define how IR shapes these immune defenses, we employ murine and human kidney cultures. When challenged with bacteria, murine ICs and human kidney cells with deregulated IR signaling cannot engage central components of the integrated stress response-including activating transcriptional factor 4 (ATF4). Silencing ATF4 impairs NFkB activation and promotes infection. In turn, NFkB silencing augments infection and suppresses antimicrobial peptide expression. In diabetic mice and people with diabetes, collecting duct cells show reduced IR expression, impaired integrated stress response engagement, and compromised immunity. Collectively, these translational data illustrate how IR orchestrates collecting duct antibacterial responses and the communication between ICs and PCs.


Sujet(s)
Souris knockout , Récepteur à l'insuline , Infections urinaires , Escherichia coli uropathogène , Animaux , Souris , Infections urinaires/microbiologie , Infections urinaires/métabolisme , Infections urinaires/immunologie , Humains , Récepteur à l'insuline/métabolisme , Escherichia coli uropathogène/immunologie , Infections à Escherichia coli/immunologie , Infections à Escherichia coli/métabolisme , Infections à Escherichia coli/microbiologie , Rein/métabolisme , Transduction du signal , Tubules collecteurs rénaux/métabolisme , Immunité innée , Souris de lignée C57BL
18.
BMJ Open ; 14(7): e082222, 2024 Jul 08.
Article de Anglais | MEDLINE | ID: mdl-38977369

RÉSUMÉ

OBJECTIVES: Most children with uncomplicated urinary tract infections (UTI) can be managed with oral antibiotics. However, identifying those likely to fail oral and need intravenous antibiotics due to complicating features at presentation is challenging. We aimed to derive, validate and test a score to guide initial antibiotic route. DESIGN: This cohort study enrolled children both prospectively and retrospectively. Patients were divided into two groups based on whether they received intravenous or oral antibiotics after 24 hours, including those who switched between routes. Children diagnosed with confirmed UTI were used to derive then validate the score, comparing complicating clinical features between the two groups. Combinations of significantly differentiating features generated receiver operating characteristic curves and the optimal cut-off for intravenous antibiotic use was selected. SETTING: The emergency department of a tertiary paediatric hospital. PARTICIPANTS: All children aged 3 months-17 years with suspected UTI were eligible, and were included if they fulfilled the diagnostic criteria for UTI. OUTCOME MEASURES: The effectiveness of the derived clinical score to differentiate patients at presentation who had complicated UTI requiring ongoing intravenous antibiotics. RESULTS: There were 1240 patients, of whom 167 children aged 12 months-11 years with confirmed UTI comprised the derivation cohort. The combination of features that performed optimally (area under curve 0.85, 95% CI 0.79 to 0.91) were: rigors, urological abnormality, fever (≥38°C), emesis, recurrent (≥3) UTI, tachycardia: the RUPERT score (1 point each, maximum 6). A score ≥3 accurately classified route of antibiotics after 24 hours for 80% patients (sensitivity 77%, specificity 81%). For the 168 patients in the validation cohort, the score accurately classified 76% (sensitivity 67%, specificity 78%). The score tested well in 'probable' UTI and adolescents, and less well in infants. CONCLUSION: The Melbourne RUPERT score provides the first standardised, easy-to-use score to aid clinicians in deciding route of antibiotics for more complicated UTI in children. It now needs prospective validation.


Sujet(s)
Antibactériens , Service hospitalier d'urgences , Infections urinaires , Humains , Infections urinaires/traitement médicamenteux , Infections urinaires/diagnostic , Antibactériens/administration et posologie , Antibactériens/usage thérapeutique , Enfant d'âge préscolaire , Femelle , Mâle , Enfant , Nourrisson , Études rétrospectives , Adolescent , Administration par voie intraveineuse , Administration par voie orale , Études prospectives , Courbe ROC
19.
Antimicrob Resist Infect Control ; 13(1): 72, 2024 Jul 06.
Article de Anglais | MEDLINE | ID: mdl-38971782

RÉSUMÉ

BACKGROUND: Before the COVID-19 pandemic there has been a constant increase in antimicrobial resistance (AMR) of Escherichia coli, the most common cause of urinary tract infections and bloodstream infections. The aim of this study was to investigate the impact of the COVID-19 pandemic on extended-spectrum ß-lactamase (ESBL) production in urine and blood E. coli isolates in Finland to improve our understanding on the source attribution of this major multidrug-resistant pathogen. METHODS: Susceptibility test results of 564,233 urine (88.3% from females) and 23,860 blood E. coli isolates (58.8% from females) were obtained from the nationwide surveillance database of Finnish clinical microbiology laboratories. Susceptibility testing was performed according to EUCAST guidelines. We compared ESBL-producing E. coli proportions and incidence before (2018-2019), during (2020-2021), and after (2022) the pandemic and stratified these by age groups and sex. RESULTS: The annual number of urine E. coli isolates tested for antimicrobial susceptibility decreased 23.3% during 2018-2022 whereas the number of blood E. coli isolates increased 1.1%. The annual proportion of ESBL-producing E. coli in urine E. coli isolates decreased 28.7% among males, from 6.9% (average during 2018-2019) to 4.9% in 2022, and 28.7% among females, from 3.0 to 2.1%. In blood E. coli isolates, the proportion decreased 32.9% among males, from 9.3 to 6.2%, and 26.6% among females, from 6.2 to 4.6%. A significant decreasing trend was also observed in most age groups, but risk remained highest among persons aged ≥ 60 years. CONCLUSIONS: The reduction in the proportions of ESBL-producing E. coli was comprehensive, covering both specimen types, both sexes, and all age groups, showing that the continuously increasing trends could be reversed. Decrease in international travel and antimicrobial use were likely behind this reduction, suggesting that informing travellers about the risk of multidrug-resistant bacteria, hygiene measures, and appropriate antimicrobial use is crucial in prevention. Evaluation of infection control measures in healthcare settings could be beneficial, especially in long-term care.


Sujet(s)
COVID-19 , Infections à Escherichia coli , Escherichia coli , Infections urinaires , bêta-Lactamases , Humains , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/isolement et purification , Escherichia coli/enzymologie , Finlande/épidémiologie , COVID-19/épidémiologie , Femelle , Infections à Escherichia coli/épidémiologie , Infections à Escherichia coli/microbiologie , Mâle , Infections urinaires/microbiologie , Infections urinaires/épidémiologie , Adulte d'âge moyen , bêta-Lactamases/métabolisme , bêta-Lactamases/biosynthèse , Sujet âgé , Adulte , Adolescent , Jeune adulte , Enfant , Nourrisson , Enfant d'âge préscolaire , Sujet âgé de 80 ans ou plus , Tests de sensibilité microbienne , SARS-CoV-2 , Nouveau-né , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Bactériémie/épidémiologie , Bactériémie/microbiologie , Multirésistance bactérienne aux médicaments , Pandémies
20.
Medicine (Baltimore) ; 103(27): e38726, 2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-38968512

RÉSUMÉ

Urinary tract infection (UTI) is a highly prevalent infection that can affect individuals of all ages, posing a significant risk to global health in terms of both morbidity and mortality. The emergence of multidrug-resistant bacteria adds to the complexity of this public health issue. There is limited data on the current study area. Therefore, this study aimed to determine the bacterial profiles, antibiotic susceptibility patterns, and associated factors of UTIs among symptomatic university students at Haramaya University, Eastern Ethiopia from May 10 to June 15, 2021. A cross-sectional study was conducted among 281 Haramaya University students. A systematic random sampling technique was used to select the study participants. Data were collected using a self-administered questionnaire. Ten to 15 mL of midstream urine samples were collected aseptically from patients. Standard microbiological techniques were used for bacterial identifications and drug susceptibility testing. The association between dependent and independent variables was determined by the logistics regression model. Variables with a P-value of <.05 were considered statistically significant. The overall prevalence of UTI among university students was 18.1% (95% confidence interval [CI]: 13.5-23.1). The most frequently isolated bacteria were Escherichia coli (33.3%) and Staphylococcus epidermidis (29.4%). Gram-negative bacteria demonstrated high resistance against ceftazidime (100%), penicillin (96%), ampicillin (92%), and tetracycline (71%). Similarly, gram-positive bacteria exhibited significant resistance to ceftazidime (100%) and ampicillin (81%). Multidrug-resistant isolates constituted an overall prevalence of 35 (68.6%) (95% CI: 63.6-73.6). Furthermore, year of study (adjusted odds ratios [AOR] = 2.66; 95% CI: 1.23-5.76), history of UTI (AOR = 2.57; 95% CI: 1.10-6.00), and sexual activity (AOR = 0.08; 95% CI: 0.02-0.39) were identified as factors. In this study, university students exhibited a higher prevalence of UTI compared to previous studies conducted in Africa. The most commonly identified bacteria causing UTIs were E coli, followed by S epidermidis. Factors such as the year of the study, presence of flank pain, history of previous UTIs, and frequency of sexual activity were found to be associated with UTIs. All the isolates have acquired resistance to the majority of commonly prescribed antibiotics. It is crucial to regularly monitor UTIs and the proliferation of antibiotic-resistant bacteria among university students.


Sujet(s)
Antibactériens , Tests de sensibilité microbienne , Étudiants , Infections urinaires , Humains , Éthiopie/épidémiologie , Infections urinaires/microbiologie , Infections urinaires/épidémiologie , Infections urinaires/traitement médicamenteux , Études transversales , Mâle , Femelle , Jeune adulte , Étudiants/statistiques et données numériques , Universités , Antibactériens/usage thérapeutique , Antibactériens/pharmacologie , Adulte , Prévalence , Adolescent , Multirésistance bactérienne aux médicaments , Facteurs de risque
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...